Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Reexamination Certificate
2011-04-26
2011-04-26
Chandrakumar, Nizal S (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
Reexamination Certificate
active
07932382
ABSTRACT:
The invention relates to conformationally constrained mimetics of Smac which function as inhibitors of Inhibitor of Apoptosis Proteins. The invention also relates to the use of these mimetics for inducing apoptotic cell death and for sensitizing cells to inducers of apoptosis.
REFERENCES:
patent: 6020331 (2000-02-01), Kahn
patent: 6608026 (2003-08-01), Wang et al.
patent: 7244851 (2007-07-01), Cohen et al.
patent: WO 97/05160 (1997-02-01), None
Hanessian et al. Tetrahedron, 53(38), 12789-12854, 1997.
Wolff, Burger's Medicinal Chemistry and Drug Discovery, vol. 1, Principles and Practice, John Wiley & Sons, New York. 1997.
Lombart et al. Journal of Organic Chemistry, 1996, 61, 9437-9446.
Flynn et al. Journal of the American Chemical Society, 1987, 109, 7914-7915.
Supplementary Search Report, European Patent Office, EP Patent Application No. EP05711521.4, dated Apr. 14, 2008.
Sun, Haiying, et al., “Structure-Based Design, Synthesis and Evaluation of Conformationally constrained Mimetics of the Second Mitochondria-Derived Activator of Caspase That Target the X-Linked Inhibitor of Apoptosis Protein/Caspase-9 Interaction Site,” J. Med. Chem, 2004, 47, 4147-4150.
Sun, Haiying, “Structure-Based Design of Potent, Conformationally Constrained Smac Mimetics,” J. Am. Chem. Soc. 2004, 126, 16686-16687.
Tamm, Ingo, “Peptides Targeting Caspase Inhibitors,” vol. 278, No. 16, Issue of Apr. 19, pp. 14401-14405, 2003, The Journal of Biological Chemistry.
Adams, Jerry M., et al., “The Bcl-2 Protein Family: Arbiters of Cell Survival,” Science, Aug. 28, 1998, vol. 281, pp. 1322-1326.
Arnt, Christina R., et al., “Synthetic Smac/DIABLO Peptides Enhance the Effects by Binding XIAP and cIPA1 in situ,” The Journal of Biological Chemistry, vol. 277, No. 46, Nov. 15, 2002, pp. 44236-44243.
Asselin, Eric, et al., “XIAP Regulates Akt Activity and Caspase-3-dependent Cleavage during Cisplatin-induced Apoptosis in Human Ovarian Epithelial Cancer Cells,” Cancer Research 61, pp. 1862-1868, Mar. 1, 2001.
Budihardjo, I., et al., “Biochemical Pathways of Caspase Activation During Apoptosis,” Annu. Rev. Cell. Dev. Biol. 1999, 15:269-90.
Chai, et al., “Structural Basis of Caspase-7 Inhibition by XIAP,” Cell, vol. 104, pp. 789-790, Mar. 9, 2001.
Deveraux, Quinn L., et al., “Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases,” The EMBO Journal vol. 18, No. 19, pp. 5242-5251, 1999.
Deveraux, Quinn L., et al., “IAP Family Proteins—Suppressors of apoptosis,” Genes & Development 13:239-252 (1999).
Deveraux, Quinn L., et al., “X-linked IAP is a direct inhibitor of cell-death proteases,” Nature 388:300 (1997).
Du, Chunying, et al., “Smac, a Mitochondrial Protein that Promotes Cytochrome c-Dependent Caspase Activation by Eliminating IAP Inhibition,” Cell, vol. 102, 33-42, Jul. 7, 2000.
Ekert, Paul G., “DIABLO Promotes Apoptosis by Removing MIHA/XIAP from Processed Caspase 9,” Cell Biology, 152:483 (2001).
Fulda, Simone, et al., “Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo,” Nature Medicine, vol. 8, No. 8, Aug. 2002.
Hofmann, Hans-Stefan, et al., “Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer,” J. Cancer Res. Clin. Oncol. (2002) 128:554-560.
Holcik, M., et al., “XIAP: Apoptotic brake and promising therapeutic target,” Apoptosis, vol. 6, No. 4 (2001), pp. 253-261.
Holcik, Martin, et al., “Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death,” Onogene (2000) 19, pp. 4174-4177.
Huang, Yihua, et al., “Structural Basis of Caspase Inhibition by XIAP: Differential Roles of the Linker versus the BIR Domain,” Cell vol. 104, pp. 781-790, Mar. 9, 2001.
Kipp, Rachel A., “Molecular Targeting of Inhibitor of Apoptosis Proteins Based on Small Molecule Mimics of Natural Binding Partners,” Biochemistry (2002) 41, pp. 7344-7349.
Lacasse, Eric C., et al., “The Inhibitors of apoptosis (IAPs) and their emerging role in cancer,” Oncogene 17:3247 (1998).
Li, Julang, et al., “Human Ovarian Cancer and Cisplatin Resistance: Possible Role of Inhibitor of Apoptosis Proteins,” Endocrinology, 142:370 (2001).
McEleny, Kevin R., et al., “Inhibitors of Apoptosis Proteins in Prostate Cancer Cell Lines,” The Prostate 51:133-140 (2002).
Ng, Chuen-Pei, et al., “X-linked inhibitor of Apoptosis (XIAP) Blocks Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis of Prostate Cancer Cells . . . ,” Molecular Cancer Therapeutics, vol. 1, pp. 1051-1058, Oct. 2002.
Reed, John C., “BCL-2 Family Proteins: Regulators of Cell Death Involved in the Pathogenesis of Cancer and Resistance to Therapy,” Journal of Cellular Biochemistry 60:23-32 (1996).
Reed, John C., “Bcl-2 Family Proteins: Strategies for Overcoming Chemoresistance in Cancer,” Advances in Pharmacology, vol. 41, (1997), pp. 501-532.
Riedl, Stefan J., et al., “Structural Basis for the Inhibition of Caspase-3 by XIAP,” Cell, vol. 104, pp. 791-800, Mar. 9, 2001.
Salvesen, Guy S., et al., “IAP Proteins: Blocking the Road to Death's Door,” Molecular Cell Biology, vol. 3, Jun. 2002, pp. 401-410.
Srinivasula, Srinivasa, et al., “A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis,” Nature, vol. 410, Mar. 1, 2001, pp. 112-116.
Srinivasula, Srinivasa, et al., “Molecular Deteminants of the Caspase-promoting Activity of Smac/DIABLO and Its Role in the Death Receptor Pathway,” The Journal of Biological Chemistry, vol. 275, No. 46, Nov. 17, 2000, pp. 36152-36157.
Sun, Chaohong, et al., “NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP,” Nature, vol. 401, Oct. 21, 1999.
Takahashi et al., “A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases,” The Journal of Biological Chemistry, vol. 273, No. 14, Apr. 3, 1998, pp. 7787-7790.
Tamm, Ingo, et al., “Expression and Prognostic Significance of IAP-Family Genes in Human Cancers and Myeloid Leukemias,” Clinical Cancer Research, vol. 6, pp. 1796-1803, May 2000.
Wu, Geng, et al., “Structural basis of IAP recognition by Smac/DIABLO,” Nature, vol. 408, Dec. 2000, pp. 1008-1012.
Yang, Lilling, et al., “Predominant Suppression of Apoptosome by Inhibitor of Apoptosis Protein in Non-Small Cell Lung Cancer H460 Cells: Therapeutic Effect of a Novel Polygarginine-conjugated Smac Peptide,” Cancer Research 63, pp. 831-837, Feb. 15, 2003.
Nikolovska-Coleska Zaneta
Sun Haiying
Wang Shaomeng
Xu Liang
Yang Chao-Yie
Casimir Jones S.C.
Chandrakumar Nizal S
The Regents of the University of Michigan
LandOfFree
Conformationally constrained Smac mimetics and the uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conformationally constrained Smac mimetics and the uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conformationally constrained Smac mimetics and the uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2696019